Aprepitant in the Treatment of Subacute Sclerosing Panencephalitis: A Randomized, Double-Blind, Placebo-Controlled Study


Oncel I., SANCAR M., KONUŞKAN B. , Arioz F., TEZCAN S., ARMAN KANDIRMAZ E., ...More

PEDIATRIC NEUROLOGY, vol.110, pp.59-63, 2020 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 110
  • Publication Date: 2020
  • Doi Number: 10.1016/j.pediatrneurol.2020.05.009
  • Title of Journal : PEDIATRIC NEUROLOGY
  • Page Numbers: pp.59-63

Abstract

Background: Aprepitant is a neurokinin-1 receptor antagonist approved for the treatment of chemotherapy-induced nausea. We aimed to investigate the safety and efficacy of aprepitant in patients with subacute sclerosing panencephalitis.